Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Metabolic syndrome markers and risk of hyperglycemia in pregnancy: a cross-sectional cohort study

Texto completo
Autor(es):
Vernini, Joice M. [1] ; Nicolosi, Bianca F. [1] ; Arantes, Mariana A. [1] ; Costa, Roberto A. [2] ; Magalhaes, Claudia G. [2] ; Corrente, Jose E. [3] ; Lima, Silvana A. M. [4] ; Rudge, Marilza V. [2, 1] ; Calderon, Iracema M. [2, 1]
Número total de Autores: 9
Afiliação do(s) autor(es):
[1] Sao Paulo State Univ Unesp, Botucatu Med Sch, Grad Program Obstet Gynecol & Mastol, Sao Paulo - Brazil
[2] Sao Paulo State Univ UNESP, Botucatu Med Sch, Dept Gynecol & Obstet, Botucatu, SP - Brazil
[3] Sao Paulo State Univ Unesp, Botucatu Inst Biosci, Dept Biostat, Sao Paulo - Brazil
[4] Sao Paulo State Univ Unesp, Botucatu Med Sch, Dept Nursing, Sao Paulo - Brazil
Número total de Afiliações: 4
Tipo de documento: Artigo Científico
Fonte: SCIENTIFIC REPORTS; v. 10, n. 1 DEC 3 2020.
Citações Web of Science: 0
Resumo

The aim was to assess the role of Metabolic Syndrome (MetS) diagnostic markers, recommended by three different guidelines, in the prediction of hyperglycemia in pregnancy. This cross-sectional cohort study included 506 non-diabetic women, with a singleton pregnancy, who underwent a diagnostic test for hyperglycemia at 24-28 weeks. Clinical, anthropometric, and laboratory data were obtained. The relationship between MetS markers and the risk of hyperglycemia was evaluated by backward stepwise logistic regression analysis (OR, 95% CI). The limit of statistical significance was 95% (p < 0.05). Triglycerides (TG) >= 150 mg/dL, blood pressure (BP) >= 130/85 mmHg, fasting glucose (FG) >= 100 mg/dL, and waist circumference (WC) > 88 cm were identified as independent risk factors for hyperglycemia in pregnancy. These results might help the selective screening of hyperglycemia in pregnancy. (AU)

Processo FAPESP: 12/51257-9 - Investigação de novos fatores de risco e da qualidade de vida, relacionados ao diagnóstico de diabete ou hiperglicemia na gestação
Beneficiário:Iracema de Mattos Paranhos Calderon
Modalidade de apoio: Auxílio à Pesquisa - Pesquisa em Políticas Públicas para o SUS